Suppr超能文献

来自β2-微球蛋白缺陷(β2m-/-)小鼠的CD8+ T细胞对同基因β2m+/+细胞的明显分裂耐受性。

Apparent split tolerance of CD8+ T cells from beta 2-microglobulin-deficient (beta 2m-/-) mice to syngeneic beta 2m+/+ cells.

作者信息

Jhaver K G, Rao T D, Frey A B, Vukmanović S

机构信息

Department of Pathology, New York University Medical Center, New York 10016, USA.

出版信息

J Immunol. 1995 Jun 15;154(12):6252-61.

PMID:7759863
Abstract

beta 2-microglobulin-deficient (beta 2m-/-) mice express reduced levels of MHC class I molecules and, consequently, have impaired positive selection of CD8+ T lymphocytes in the thymus. However, small numbers of CD8+ CTLs can be found in beta 2m-/- mice after immunization with allogeneic as well as syngeneic beta 2m+/+ tumor or spleen cells. It has been proposed, therefore, that because of the low ligand density in beta 2m-/- mice, negative selection does not remove cells capable of recognizing syngeneic MHC class I expressed at normal levels. We report here that beta 2m-/- CD8+ T cells are partially tolerant to syngeneic beta 2m+/+ cells. Despite the ability of beta 2m-/- mice to raise CD8+ CTLs against syngeneic beta 2m+/+ cells, these CD8+ cells do not proliferate and do not secrete IFN-gamma or IL-3/granulocyte-macrophage-CSF upon in vitro stimulation with syngeneic beta 2m+/+ cells. In contrast, all of these cellular responses are displayed by the beta 2m-/- CD8+ cells upon recognition of the allogeneic MHC class I. These in vitro findings of partial responsiveness to syngeneic and of full responsiveness to allogeneic MHC class I correlate well with the ability of beta 2m-/- mice to reject allogeneic, but not syngeneic, tumors in vivo. It appears, thus, that the significantly reduced levels of MHC class I molecules found in beta 2m-/- mice, although not capable of inducing deletion of all reactive clones, can induce deletion of high affinity clones and, therefore, maintain tolerance to self-MHC class I, even when expressed at much higher (beta 2m+/+) levels.

摘要

β2微球蛋白缺陷(β2m-/-)小鼠表达的MHC I类分子水平降低,因此,其胸腺中CD8+ T淋巴细胞的阳性选择受损。然而,在用同种异体以及同基因的β2m+/+肿瘤细胞或脾细胞免疫后,在β2m-/-小鼠中可发现少量CD8+ CTL。因此,有人提出,由于β2m-/-小鼠中配体密度低,阴性选择不会清除能够识别正常水平表达的同基因MHC I类分子的细胞。我们在此报告,β2m-/- CD8+ T细胞对同基因的β2m+/+细胞具有部分耐受性。尽管β2m-/-小鼠有能力产生针对同基因β2m+/+细胞的CD8+ CTL,但这些CD8+细胞在体外受到同基因β2m+/+细胞刺激时不会增殖,也不会分泌IFN-γ或IL-3/粒细胞-巨噬细胞集落刺激因子。相反,当识别同种异体MHC I类分子时,β2m-/- CD8+细胞会表现出所有这些细胞反应。这些体外实验结果表明,β2m-/- CD8+细胞对同基因MHC I类分子的部分反应性以及对同种异体MHC I类分子的完全反应性与β2m-/-小鼠在体内排斥同种异体肿瘤而非同基因肿瘤的能力密切相关。因此,似乎在β2m-/-小鼠中发现的MHC I类分子水平显著降低,虽然不能诱导所有反应性克隆的缺失,但可以诱导高亲和力克隆的缺失,因此,即使在更高(β2m+/+)水平表达时,也能维持对自身MHC I类分子的耐受性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验